Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 765 results: Page 1 of 31


Tier Species Size Attr. GeneSet
Tier I 12152 GS232685: PC Geneset - "Homo sapiens" pathway genes
Tier IV 9412 GS404756: Up regulated genes from caudate nucleus (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 9299 GS408186: Differential gene expression comparison between Carnegie Stages (CS) 17 and 22 during human embryo craniofacial development, log2FC
Tier IV 9299 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 13854 GS408212: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_coefficient
Tier IV 13854 GS408213: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_qvalue
Tier IV 13854 GS408215: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) in human opioid use disorder subjects_coefficient
Tier IV 13854 GS408217: Transcriptional differences in nucleus accumbens (NAc) in human opioid use disorder subjects_coefficient
Tier IV 169 GS408222: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_log2FC
Tier IV 169 GS408223: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_qvalue
Tier IV 87 GS408224: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Mendez et al 2021_log2FC
Tier IV 17285 GS408225: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_metaanalysis_qvalue
Tier IV 54 GS408226: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Seney et al 2021_log2FC
Tier IV 54 GS408227: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Seney et al 2021_qvalue